United States Cardiac Rhythm Management Devices Market Outlook to 2025

  • ID: 4532596
  • Report
  • Region: United States
  • 97 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Biotronik AG
  • Boston Scientific Corp
  • Medtronic Plc
  • MORE
United States Cardiac Rhythm Management Devices Market Outlook to 2025

Summary

The new report, United States Cardiac Rhythm Management Devices Market Outlook to 2025, provides key market data on the United States Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Cardiac Rhythm Management Devices market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for Cardiac Rhythm Management Devices market.
  • Global corporate-level profiles of key companies operating within the United States Cardiac Rhythm Management Devices market.
  • Key players covered include Medtronic plc, Abbott Laboratories, Boston Scientific Corp. and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Biotronik AG
  • Boston Scientific Corp
  • Medtronic Plc
  • MORE
1 Table of Contents

2 Introduction
2.1 What Is This Report About?
2.2 Cardiac Rhythm Management Devices Segmentation
2.3 Definitions of Markets Covered in the Report

3 Cardiac Rhythm Management Devices Market, United States
3.1 Cardiac Rhythm Management Devices Market, United States, Revenue ($m), 2015-2025
3.1.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.3 Pacemakers Market, United States, Revenue ($m), by Segment, 2015-2025
3.2 Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2015-2025
3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2015-2025
3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2015-2025
3.2.3 Pacemakers Market, United States, Volume (Units), by Segment, 2015-2025
3.3 Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2015-2025
3.4 Cardiac Rhythm Management Devices Market, United States, Distribution Share by Revenue ($m), 2017
3.5 Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), 2017

4 Overview of Key Companies in United States, Cardiac Rhythm Management Devices Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Abbott Laboratories
4.2.1 Company Overview
4.3 Boston Scientific Corp
4.3.1 Company Overview
4.4 Biotronik AG
4.4.1 Company Overview

5 Cardiac Rhythm Management Devices Market Pipeline Products

6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Royal Philips Acquires Spectranetics
6.2 Debt Offerings
6.2.1 Boston Scientific Raises USD1 Billion in Public Offering of 4% Notes Due 2028
6.3 Equity Offerings
6.3.1 MRI Interventions Raises USD13.3 Million in Private Placement of Units
6.4 Private Equity
6.4.1 EBR Systems Raises USD50 Million in Financing Round
6.4.2 3i Group to Invest USD136 Million in Cirtec Medical Systems from Century Park Capital Partners
6.5 Venture Financing
6.5.1 Corinnova Raises USD6.1 Million from Wellcome Trust
6.5.2 CorInnova Raises USD0.3 Million in Venture Financing

7 Recent Developments
7.1 Corporate Communications
7.1.1 Apr 15, 2018: Genentech to Present Phase Ib/II Study Results of RG6206
7.1.2 Apr 10, 2018: iRhythm Technologies Appoints UCLA and Cedars-Sinai Professor C. Noel Bairey Merz, M.D. to its Board of Directors
7.1.3 Mar 13, 2018: Orthofix Announces Appointment of John Sicard to Board of Directors
7.1.4 Feb 13, 2018: Proteus Digital Health Appoints Joseph Swedish As Board Director
7.1.5 Jan 10, 2018: Ventripoint Appoints Head of Sales for North America
7.1.6 Dec 19, 2017: Ventripoint Diagnostics Provides Corporate Update
7.1.7 Nov 20, 2017: Follicum applies for the start of a Phase II study at the German Medicines Agency
7.1.8 Oct 11, 2017: New Data Shows That for Some Patients, Deep Brain Stimulation May Address Chronic Depression
7.1.9 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
7.1.10 Sep 05, 2017: Former U. S. Surgeon General Dr. Regina Benjamin Joins the Board of Proteus Digital Health
7.1.11 Aug 23, 2017: Senior Novartis Executive Joins Proteus Digital Health as Chief Financial Officer
7.1.12 Jul 20, 2017: A Third Highly Successful Ultrasound Executive joins Ventripoint
7.1.13 Jun 21, 2017: Highly Successful Global Industry Sales & Marketing Executives Hired by Ventripoint
7.1.14 Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors
7.2 Financial Announcements
7.2.1 Apr 16, 2018: USRM Reports 2017 Financial Results
7.2.2 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results
7.2.3 Mar 06, 2018: Stereotaxis Reports 2017 Fourth Quarter And Full Year Financial Results
7.2.4 Feb 26, 2018: Orthofix International Reports Fourth Quarter And Fiscal 2017 Financial Results
7.2.5 Feb 08, 2018: Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance
7.2.6 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
7.2.7 Jan 23, 2018: Glytec's Software Yields Superior Patient Outcomes According to Four New Studies in Journal of Diabetes Science and Technology
7.2.8 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
7.2.9 Jan 09, 2018: Orthofix Announces Preliminary 2017 Fourth Quarter and Full Year Net Sales Results
7.2.10 Jan 08, 2018: Stereotaxis Reports Preliminary Fourth Quarter 2017 Revenue Results
7.2.11 Dec 12, 2017: Cyclacel Announces Presentation of Results From Phase 3 Seamless Study at Ash Annual Meeting
7.2.12 Nov 09, 2017: Stereotaxis Reports Third Quarter 2017 Financial Results
7.2.13 Nov 08, 2017: Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance
7.2.14 Nov 01, 2017: iRhythm Technologies Announces Third Quarter 2017 Financial Results And Raises Guidance For Full Year 2017
7.2.15 Oct 30, 2017: Orthofix International Reports Third Quarter 2017 Financial Results
7.2.16 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017
7.2.17 Oct 25, 2017: Bard Announces Third Quarter Results
7.2.18 Sep 26, 2017: Psychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair Test
7.2.19 Sep 26, 2017: DFB Soria Gives Update on Enrollment in Phase 2 Clinical Trial of SOR007 (Nanoparticle Paclitaxel) Ointment for Actinic Keratosis (AK)
7.2.20 Aug 29, 2017: Medovex Receives Regulatory Approval from Australia's Therapeutic Goods Administration for its DenerveX System
7.2.21 Aug 15, 2017: CareRay Exhibits At FIME 2017
7.2.22 Aug 10, 2017: Stereotaxis Reports Second Quarter 2017 Financial Results
7.2.23 Aug 09, 2017: U.S. Stem Cell Reports Most Successful Financial Performance in the Company's History
7.2.24 Aug 07, 2017: Orthofix International Reports Second Quarter 2017 Financial Results
7.2.25 Aug 03, 2017: Surmodics Reports Third Quarter Fiscal 2017 Results and Updates Fiscal 2017 Guidance
7.2.26 Aug 03, 2017: Spectranetics Reports Second Quarter 2017 Revenue of $74.7 million
7.2.27 Aug 02, 2017: iRhythm Technologies Announces Second Quarter 2017 Financial Results
7.2.28 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
7.2.29 Jun 21, 2017: Tolero Pharmaceuticals to Expand Enrollment of Phase II Study of Alvocidib in MCL-1-Dependent AML into Europe
7.2.30 May 08, 2017: Stereotaxis Reports 2017 First Quarter Financial Results
7.2.31 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017
7.2.32 Apr 27, 2017: Surmodics Reports Second Quarter Fiscal 2017 Results, Updates Fiscal 2017 Financial Guidance
7.2.33 Apr 27, 2017: Spectranetics Reports First Quarter 2017 Revenue of $69.7 million
7.3 Legal And Regulatory
7.3.1 Aug 28, 2017: FDA warns US Stem Cell Clinic of significant deviations
7.3.2 Aug 03, 2017: Zoll Announces Jury Verdict in Zoll/Philips Patent Dispute
7.3.3 May 31, 2017: AngioDynamics Lawsuit Alleges C.R. Bard is Violating Antitrust Laws, Harming Competition and Limiting Access
7.4 Other Significant Developments
7.4.1 Feb 06, 2018: USRM Seeing Explosive Increase in Demand for Stem Cell Therapy
7.4.2 Aug 28, 2017: U.S. Stem Cell Clinic Acknowledges Warning Letter By The FDA and Responds
7.4.3 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
7.4.4 Jun 01, 2017: Nexus Pharmaceuticals Receives FDA Approval for Sodium Nitroprusside Injection
7.5 Product News
7.5.1 Nov 27, 2017: Ventripoint Invents a New Way to Track Ultrasound Probes That Will Speed up Exams
7.6 Strategy And Business Planning
7.6.1 Feb 07, 2018: Caisson Interventional Expanding in Maple Grove
7.6.2 Dec 11, 2017: Anthera Pharmaceuticals Announces Positive Outcome of Interim Futility Analysis in the Phase 3 RESULT Clinical Study of Sollpura

8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 Consulting
8.3 Contact
8.4 Disclaimer

List of Tables
Table 1: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 2: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 3: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 4: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 5: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 6: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 7: Pacemakers Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 8: Pacemakers Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 9: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2015-2020
Table 10: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2021-2025
Table 11: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2015-2020
Table 12: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2021-2025
Table 13: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2015-2020
Table 14: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2021-2025
Table 15: Pacemakers Market, United States, Volume (Units), 2015-2020
Table 16: Pacemakers Market, United States, Volume (Units), 2021-2025
Table 17: Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2015-2020
Table 18: Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2021-2025
Table 19: Cardiac Rhythm Management Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017
Table 20: Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2017
Table 21: Cardiac Rhythm Management Devices Market Pipeline Products
Table 22: Royal Philips Acquires Spectranetics
Table 23: Boston Scientific Raises USD1 Billion in Public Offering of 4% Notes Due 2028
Table 24: MRI Interventions Raises USD13.3 Million in Private Placement of Units
Table 25: EBR Systems Raises USD50 Million in Financing Round
Table 26: 3i Group to Invest USD136 Million in Cirtec Medical Systems from Century Park Capital Partners
Table 27: Corinnova Raises USD6.1 Million from Wellcome Trust
Table 28: CorInnova Raises USD0.3 Million in Venture Financing
Table 29: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country

List of Figures
Figure 1: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 2: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 3: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 4: Pacemakers Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 5: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2015-2025
Figure 6: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2015-2025
Figure 7: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2015-2025
Figure 8: Pacemakers Market, United States, Volume (Units), 2015-2025
Figure 9: Cardiac Rhythm Management Devices Market, United States, Company Share (%) 2017
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Medtronic Plc
  • Abbott Laboratories
  • Boston Scientific Corp
  • Biotronik AG
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll